Cell proliferation, nuclear ploidy, and EGFr and HER2/neu tyrosine kinase oncoproteins in infiltrating ductal breast carcinoma

Cancer Genetics and Cytogenetics

Volumn 138, Issue 1, 2002, Pages 69-72

  Val, J F Fernandez ^a   Losada, J ^a   Murua, M A Arregui ^a   Sarria R ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MEMBRANE PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; CANCER INFILTRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIPLOIDY; DISEASE SEVERITY; DNA CONTENT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIVISION; CELL NUCLEUS; FEMALE; FLOW CYTOMETRY; HUMANS; PLOIDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; S PHASE;

EID: 0036805488     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00567-8     Document Type: Article

References (20)

1. Programa de detección precoz del cáncer de mama en la Comunidad Autónoma del País Vasco. Boletín. Junio 2001.
2. Cady B., Stone M., Schuler J., Thakur R., Wanner M., Lavin P. The new era in breast cancer. Arch Surg. 131:1996;301-308.
3. Tavossoli F.A. Pathology of the breast. 2nd edition:1999;Appleton & Lange, Stanford.
4. Fitzgibbons P.L., Page D.L., Weaver D., Thor A.D., Allred D.C., Clark G.M., Ruby S.G., O'Malley F., Simpson J.F., Connolly J.L., Hayes D.F., Edge S.B., Lichter A., Schnitt S.J. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 124:2000;966-978.
5. McCoy J.P., Overton W.R. A survey of current practices in clinical flow cytometry. Am J Clin Pathol. 106:1996;82-86.
6. Dobrynin I.V., Nikolaeva T.G., Letiagin V.P., Alferov V.S., Prorokov V.V. DNA ploidy of tumor cells in prognostication of the course of malignant neoformations. Vestn Ross Akad Med Nauk. 4:1995;45-50.
7. Camplejohn R.S., Ash C.M., Gillett C.E., Raikundalia B., Barnes D.M., Gregory W.M., Richards M.A., Millis R.R. The prognostic significance of DNA flow cytometry in breast cancer. results from 881 patients treated in a single center Br J Cancer. 71:1995;140-145.
8. Sigurdsson H., Baldetorp B., Borg A., Dalberg M., Fernö M., Kilander D., Olsson H., Ranstam J. Flow cytometry in primary breast cancer. improving the prognostic value of the fraction of cells in the S-Phase by optimal categorisation of cut-off levels Br J Cancer. 62:1990;786-790.
9. Rajkulmar T., Machin L.J., Gullick J. The type 1 growth factors in human breast cancer. Breast Cancer Res Treat. 29:1994;3-9.
10. Seshadri B.R., Firgaira F.A., Horsfall D.J. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. J Clin Oncol. 11:1993;1936-1942.
11. Hedley D.W., Friedlander M.L., Taylor I.W., Rugg Ca Musgrove E.A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 31:1983;1333-1335.
12. Hedley D.W., Clark G.M., Cornelisse C.J., Killander D., Kute K., Merkel D. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry. 14:1993;482-485.
13. Hsu S.M., Raine L., Fangher H.A. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol. 75:1981;734-738.
14. Wenger C.R., Beardslee S., Owens M.A.et al. DNA ploidy, S-phase fraction and steroid receptors in more than 100,000 breast cancers. Proc Annu Meet Am Soc Clin Oncol. 11:1992;A130.
15. Shibata Y., Ochiai A., Kanai Y. Dominant negative inhibition of the association between beta-catein and c-erbB-2 by N-terminally deleted beta-catein suppresses the invasion and metastasis of cancer cells. Oncogene. 13:1996;883-889.
16. Oehler M.K., Rehn M., Kristen P., Sutterlin M., Caffier H. Correlation of the EGF-receptor with cell kinetic and classical prognostic factors in breast cancer. Anticancer Res. 17:1997;3137-3140.
17. Falette N., Lefebvre M.F., Meggouh F., Eynard M., Garin E., Saez S. Measurement of occupied and non-occupied epidermal growth factor receptor sites in 216 human breast cancer biopsies. Breast Cancer Res Treat. 20:1992;177-183.
18. Ried T., Just K.E., Holtgreve-Grez H., Manoir S., Speicher M., Schrock E., Latham C., Blegen H., Zetterberg A., Cremer T., Auer G. Comparative genomic hybridization of formalin-fixed, paraffin embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res. 55:1995;5415-5423.
19. Tanner M., Tirkkonen M., Kallioniemi A., Holli K., Collins C., Kowbel D., Gray J.W., Kallioniemi O.P., Isola J. Amplification of chromosomal region 20q13 in invasive breast cancer. prognostic implications Clin Cancer Res. 1:1995;1455-1461.
20. Zimonjic D.B., Keck-Waggoner C.L., Yuan B.Z., Kraus M.H., Popescu N.C. Profile of genetic alterations and tumorigenicity of human breast cancer cells. Int J Oncol. 16:2000;221-230.